J7J Stock Overview
Focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
My Notes
Capture your thoughts, links and company narrative
Monogram Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.40 |
| 52 Week High | US$4.40 |
| 52 Week Low | US$1.33 |
| Beta | 0 |
| 1 Month Change | 25.00% |
| 3 Month Change | 15.38% |
| 1 Year Change | -9.09% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -22.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| J7J | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -6.3% | -0.5% | -0.3% |
| 1Y | -9.1% | -8.4% | 7.0% |
Return vs Industry: J7J matched the German Medical Equipment industry which returned -8.4% over the past year.
Return vs Market: J7J underperformed the German Market which returned 7% over the past year.
Price Volatility
| J7J volatility | |
|---|---|
| J7J Average Weekly Movement | 14.7% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: J7J's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: J7J's weekly volatility has decreased from 22% to 15% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 28 | Ben Sexson | www.monogramorthopedics.com |
Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens.
Monogram Technologies Inc. Fundamentals Summary
| J7J fundamental statistics | |
|---|---|
| Market cap | €85.39m |
| Earnings (TTM) | -€15.12m |
| Revenue (TTM) | €350.69k |
243.5x
P/S Ratio-5.6x
P/E RatioIs J7J overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| J7J income statement (TTM) | |
|---|---|
| Revenue | US$365.00k |
| Cost of Revenue | US$0 |
| Gross Profit | US$365.00k |
| Other Expenses | US$16.10m |
| Earnings | -US$15.73m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.46 |
| Gross Margin | 100.00% |
| Net Profit Margin | -4,310.41% |
| Debt/Equity Ratio | 0% |
How did J7J perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 17:12 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Monogram Technologies Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Wittes | Roth MKM |
| Thomas Kerr | Zacks Small-Cap Research |